Skip to main content
Fig. 1 | BMC Nephrology

Fig. 1

From: Indoxyl sulfate – the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease

Fig. 1

The levels of IS in control group and CKD group (left) and comparison of the levels of IS among the patients with the different stage of CKD (right). *** p < 0.001 controls vs CKD group; ^^^ p < 0.001 patients with CKD with III (n = 10) /IV (n = 9) /V (n = 21) stage vs I + II stage (n = 11). Abbreviations: IS - indoxyl sulfate; CKD - chronic kidney disease; NS - non-significant

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us